IMARC Group's report titled "Biosurgery Market Report by Product (Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple Line Reinforcement), Source (Natural/Biologics Products, Synthetic Products), Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032". The global biosurgery market size reached US$ 13.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/biosurgery-market/requestsample
Factors Affecting the Growth of the Biosurgery Industry:
The continuous advancements in surgical technologies, including innovative biomaterials and enhanced surgical techniques, are bolstering the market growth. Developments in biologics that facilitate wound healing, tissue regeneration, and bone growth are pivotal. Surgeries are becoming more complex, which is driving the demand for products that reduce intraoperative and postoperative complications, such as adhesives, sealants, and hemostatic agents. The integration of technology like smart biologics, which are materials engineered to interact with human tissues in specific ways, is contributing to the market growth. These technologies not only improve clinical outcomes but also shorten hospital stays and reduce healthcare costs, making them highly desirable in surgical applications.
Conditions, such as cancer, diabetes, and obesity, often require surgical interventions that utilize biosurgical products for tissue management, wound closure, and postoperative recovery. The aging demographic is particularly influential as older adults undergo more orthopedic procedures, including joint replacement and spinal fusion surgeries, which frequently employ biosurgery products. Additionally, the prevalence of age-related ailments that necessitate surgical interventions is catalyzing the demand for biosurgical solutions. These demographic trends ensure a steady demand for biosurgical advancements as healthcare systems strive to meet the surgical needs of an expanding elderly population while managing chronic disease complications effectively.
Strategic collaborations and mergers among key players are enabling companies to expand their product portfolios, leverage the strengths of each other in technology and market reach, and accelerate research and development (R&D). Besides this, partnerships between biotechnology firms and medical device companies often lead to innovative combinations of biological agents and delivery systems, enhancing the effectiveness and application range of biosurgical products. Mergers and acquisitions (M&A) also allow for the consolidation of market positions and improvement in operational efficiencies, reducing costs and expanding international footprints. These strategic moves not only enhance the capabilities of the companies involved but also drive sales by bringing more advanced solutions to the forefront.
Leading Companies Operating in the Global Biosurgery Industry: